Patents
US patents through Dec 31, 2025 · PatentsView, from the USPTO’s Open Data Portal · read Oct 27, 2026
24 patents granted to the 5 names below, as the owner printed on each patent when it was granted. A later sale, a lapse or an expiry is not read, so this is what was granted to Axe Compute Inc.’s names, not what it holds today.
Patents granted
24
24 utility, 1976 to Dec 31, 2025
Granted in 2025
none
in the last year the record reads
Applications published
28
since 2001, to Dec 31, 2025
Names they are printed under
5
a former name, a subsidiary
By yearGrantedApplications published
'02'04'05'06'08'09'10'11'12'14'15'16'18'19'21
Each pair is one calendar year. Applications are published about eighteen months after filing, so the newest years read low.
What they are aboutgrants since 2021
The main technology area of each patent, in the World Intellectual Property Organization’s 35 fields.
Under which name5 counted
Precision Therapeutics, Inc. a former name
US, as the owner printed on each patent
21 publishedBioDrain Medical, Inc. a former name
US, as the owner printed on each patent
3 publishedHELOMICS CORPORATION a subsidiary
named as the applicant on its applications, in US
2 publishedSkyline Medical Inc. a former name
named as the applicant on its applications, in US
2 publishedSkyline Medical, Inc. a former name
US, as the owner printed on each patent
0 published
Newest grantseach row opens the USPTO’s own copy
| Granted | Patent | Title | Field | Owner as printed |
|---|
| Mar 23, 2021 | 10,954,975 | Fluid waste collection and disposal system and method | Medical technology | Skyline Medical, Inc. |
| Apr 9, 2019 | 10,253,792 | Fluid waste collection and disposal system and method | Medical technology | Skyline Medical, Inc. |
| Aug 7, 2012 | 8,236,489 | Chemo-sensitivity assays using tumor cells exhibiting persistent phenotypic characteristics | Analysis of biological materials | Precision Therapeutics, Inc. |
| May 29, 2012 | 8,187,800 | Methods for selecting active agents for cancer treatment | Analysis of biological materials | Precision Therapeutics, Inc. |
| May 22, 2012 | 8,183,009 | Assaying cellular markers for the evaluation of tumors | Pharmaceuticals | Precision Therapeutics, Inc. |
| Feb 28, 2012 | 8,123,731 | Method and apparatus for disposing of liquid surgical waste for protection of healthcare workers | Medical technology | BioDrain Medical, Inc. |
| Nov 15, 2011 | 8,058,025 | Methods for determining efficacy of chemotherapeutic agents | Pharmaceuticals | Precision Therapeutics, Inc. |
| Oct 18, 2011 | 8,039,213 | Methods for assessing efficacy of chemotherapeutic agents | Biotechnology | Precision Therapeutics, Inc. |
| Jul 5, 2011 | 7,972,769 | Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays | Analysis of biological materials | Precision Therapeutics, Inc. |
| Nov 9, 2010 | 7,829,288 | Methods for assessing efficacy of chemotherapeutic agents | Biotechnology | Precision Therapeutics, Inc. |
Newest applications publishedan application is a clue, never a plan
| Published | Application | Title | Field | Owner as printed |
|---|
| Aug 1, 2019 | 2019/0234437 | FLUID WASTE COLLECTION AND DISPOSAL SYSTEM AND METHOD | Medical technology | Skyline Medical Inc. · patent 10,954,975 granted from it |
| Feb 22, 2018 | 2018/0052168 | EX VIVO LIQUID BIOPSY | Analysis of biological materials | HELOMICS CORPORATION |
| Oct 6, 2016 | 2016/0292381 | METHODS OF SIMULATING CHEMOTHERAPY FOR A PATIENT | Analysis of biological materials | HELOMICS CORPORATION |
| Dec 17, 2015 | 2015/0362000 | FLUID WASTE COLLECTION AND DISPOSAL SYSTEM AND METHOD | Medical technology | Skyline Medical Inc. · patent 10,253,792 granted from it |
| Mar 13, 2014 | 2014/0072999 | METHODS OF SIMULATING CHEMOTHERAPY FOR A PATIENT | Analysis of biological materials | Precision Therapeutics, Inc. |
| Dec 27, 2012 | 2012/0329086 | CHEMO-SENSITIVITY ASSAYS USING TUMOR CELLS EXHIBITING PERSISTENT PHENOTYPIC CHARACTERISTICS | Analysis of biological materials | Precision Therapeutics, Inc. |
| Aug 30, 2012 | 2012/0219982 | METHODS FOR SELECTING ACTIVE AGENTS FOR CANCER TREATMENT | Analysis of biological materials | Precision Therapeutics, Inc. |
| Aug 23, 2012 | 2012/0214679 | METHODS AND SYSTEMS FOR EVALUATING THE SENSITIVITY OR RESISTANCE OF TUMOR SPECIMENS TO CHEMOTHERAPEUTIC AGENTS | Biotechnology | Precision Therapeutics, Inc. |
| Apr 12, 2012 | 2012/0088264 | METHODS FOR DETERMINING EFFICACY OF CHEMOTHERAPEUTIC AGENTS | Pharmaceuticals | Precision Therapeutics, Inc. |
| Sep 29, 2011 | 2011/0238322 | METHODS OF SIMULATING CHEMOTHERAPY FOR A PATIENT | Analysis of biological materials | Precision Therapeutics, Inc. |
A patent is counted where the owner printed on it when it was granted carries the company’s own name, a former name, the name of a subsidiary its annual report lists, or its own name with a patent-holding phrase (Technology Licensing, Intellectual Property and the like), once the legal form, case and punctuation are set aside, and prints a country that name counts in. PatentsView’s data are published under the Creative Commons Attribution 4.0 licence. Source: PatentsView's granted patents and pre-grant publications, disambiguated, from the USPTO's Open Data Portal, through Dec 31, 2025, read Oct 27, 2026.